Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease by Sagar S. Bachhav, Ana Victoria Ponce‐Bobadilla, Diana Clausznitzer, Sven Stodtmann, Hao Xiong

Subjects: Get full text

Model-informed drug development of novel ROCK2 inhibitor TDI01: population pharmacokinetic study and simulation by Xiwei Ji, Yimin Cui

Subjects: Get full text

A mechanistic quantitative systems pharmacology model platform for translational efficacy evaluation and checkpoint combination design of bispecific immuno-modulatory antibodies by Yiyang Xu, Siyuan Yang, Qi Rao, Yuan Gao, Guanyue Zhou, Dongmei Zhao, Xinsheng Shi, Yi Chai, Chen Zhao, Chen Zhao

Subjects: Get full text

Editorial: Application of PKPD modeling in drug discovery and development by Hong-Can Ren, Xiao Zhu, Kun Hao, Si-Yuan Le

Subjects: Get full text

Corrigendum: Mathematical modeling in autoimmune diseases: from theory to clinical application by Yaroslav Ugolkov, Yaroslav Ugolkov, Yaroslav Ugolkov, Antonina Nikitich, Antonina Nikitich, Cristina Leon, Gabriel Helmlinger, Kirill Peskov, Kirill Peskov, Kirill Peskov, Kirill Peskov, Victor Sokolov, Victor Sokolov, Alina Volkova, Alina Volkova

Subjects: Get full text

Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies by Morris Muliaditan, Tamara J. van Steeg, Lindsay B. Avery, Wei Sun, Timothy R. Hammond, Diana Hijdra, Siak-Leng Choi, Nikhil Pillai, Nina C. Leksa, Panteleimon D. Mavroudis

Subjects: Get full text